Carnegie Mellon University scientists are breaking new ground with their development of AggreBots—tiny, living robots crafted from human lung cells. These innovative biological machines, designed by the Ren lab, promise a new era in precision medicine. AggreBots operate at a microscale, allowing them to navigate intricate pathways inside the human body and deliver targeted treatments right where they’re needed.
How AggreBots Work
The team at Carnegie Mellon uses advanced engineering to create these “designer” biobots. By harnessing the natural properties of lung cells, researchers have built robots that can move, adapt, and potentially respond to their environment inside the body. The primary vision is to use AggreBots for delivering medicine with pinpoint accuracy—minimizing side effects and maximizing effectiveness.
Potential Impact on Healthcare
AggreBots could transform how doctors treat diseases, from cancer to chronic illnesses, by bringing medication directly to affected cells. This approach may also open doors to new therapies and smarter drug delivery systems. As research progresses, AggreBots might soon become a vital tool for personalized medicine, helping patients heal faster with fewer complications.
Sources: Phys.org
